Compare TARG to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 8.50 |
|---|---|
| Trade Time: | Nov 17 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 8.50 |
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 2.00 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | N/A |
| Volume: | 0 |
| Avg Vol (3m): | N/A |
| Market Cap: | N/A |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
| Wed, Feb 25 | The Medicines Company Announces Completion of Tender Offer for Shares of Targanta TherapeuticsMarketwire |
| Tue, Jan 27 | The Medicines Company Commences Tender Offer for All Outstanding Shares of Targanta TherapeuticsMarketwire |
| Wed, Jan 14 | TARGANTA THERAPEUTICS CORP. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online |
| Tue, Jan 13 | Biotech Shares, Options Spike on Lilly Deal Talkat CNBC |
| Tue, Jan 13 | Targanta Gets Needed Medicineat Forbes.com |
| Tue, Jan 13 | Medicines Co. to Acquire Targantaat TheStreet.com |
| Mon, Jan 12 | The Medicines Company to Acquire Targanta TherapeuticsMarketwire |
| Mon, Jan 12 | [$$] Reasons to Look for a Rise This Weekat RealMoney by TheStreet.com |
| Fri, Dec 19 | TARGANTA THERAPEUTICS CORP. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in DirectorEDGAR Online |
| Tue, Dec 9 | TARGANTA THERAPEUTICS CORP. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.